New Research Shows Point-of-Care Patient Outreach Supports Vaccine Confidence and Adoption
New research by Phreesia reveals that delivering digital vaccine-related messages to patients before medical appointments significantly increases vaccine uptake. The study, analyzing over 20.2 million digital vaccine messages across all 50 states between March 2020 and May 2024, found that patients exposed to point-of-care messages received vaccinations at a rate more than twice as high as control groups. Key findings include:
- 49% of patients said the information was new to them
- 65% were likely to discuss vaccines with their doctor
- In some cases, messaging drove vaccine administration rates more than 10X higher than the control group
The research demonstrates the effectiveness of providing timely, credible vaccine information in supporting vaccine confidence and adoption, even among historically marginalized populations and during periods of increased vaccine hesitancy.
Una nuova ricerca di Phreesia rivela che la consegna di messaggi digitali relativi ai vaccini ai pazienti prima degli appuntamenti medici aumenta significativamente l'assunzione del vaccino. Lo studio, che ha analizzato oltre 20,2 milioni di messaggi digitali sui vaccini in tutti i 50 stati tra marzo 2020 e maggio 2024, ha scoperto che i pazienti esposti ai messaggi point-of-care hanno ricevuto vaccinazioni a un tasso più di due volte superiore rispetto ai gruppi di controllo. Le principali scoperte includono:
- Il 49% dei pazienti ha dichiarato che le informazioni erano nuove per loro
- Il 65% era propenso a discutere dei vaccini con il proprio medico
- In alcuni casi, la messaggistica ha portato a tassi di somministrazione del vaccino più di 10 volte superiori rispetto al gruppo di controllo
La ricerca dimostra l'efficacia di fornire informazioni sui vaccini tempestive e credibili nel sostenere la fiducia e l'adozione dei vaccini, anche tra popolazioni storicamente emarginate e durante periodi di maggiore esitazione vaccinale.
Una nueva investigación de Phreesia revela que enviar mensajes digitales relacionados con las vacunas a los pacientes antes de las citas médicas aumenta significativamente la adopción de la vacuna. El estudio, que analizó más de 20,2 millones de mensajes digitales sobre vacunas en los 50 estados entre marzo de 2020 y mayo de 2024, encontró que los pacientes expuestos a mensajes en el punto de atención recibieron vacunaciones a un ritmo más de dos veces superior al de los grupos de control. Las principales conclusiones incluyen:
- El 49% de los pacientes dijo que la información era nueva para ellos
- El 65% tenía más probabilidades de discutir las vacunas con su médico
- En algunos casos, los mensajes impulsaron las tasas de administración de vacunas más de 10 veces superiores a las del grupo de control
La investigación demuestra la efectividad de proporcionar información sobre vacunas oportuna y creíble para apoyar la confianza y adopción de vacunas, incluso entre poblaciones históricamente marginadas y durante periodos de mayor vacilación sobre las vacunas.
Phreesia의 새로운 연구에 따르면, 의료 예약 전에 환자에게 디지털 백신 관련 메시지를 전달하는 것이 백신 접종률을 크게 증가시킨다고 합니다. 이 연구는 2020년 3월부터 2024년 5월까지 50개 주 전역에서 2020만 개의 디지털 백신 메시지를 분석하며, 포인트 오브 케어 메시지에 노출된 환자들이 대조군보다 두 배 이상 높은 백신 접종률을 보였다고 밝혔습니다. 주요 발견 사항은 다음과 같습니다:
- 환자의 49%가 이 정보가 자신에게는 새로운 것이라고 응답
- 65%가 의사와 백신에 대해 논의할 가능성이 높았음
- 경우에 따라, 메시지는 대조군보다 10배 이상 높은 백신 접종률을 가져왔음
이 연구는 적시의 신뢰할 수 있는 백신 정보를 제공하는 것이 백신에 대한 신뢰와 채택을 지원하는 데 효과적임을 보여주며, 역사적으로 소외된 인구와 백신 주저가 증가하는 시기에도 해당한다고 합니다.
Une nouvelle recherche de Phreesia révèle que l'envoi de messages numériques concernant les vaccins aux patients avant les rendez-vous médicaux augmente de manière significative l'adoption des vaccins. L'étude, analysant plus de 20,2 millions de messages numériques sur les vaccins dans les 50 états entre mars 2020 et mai 2024, a constaté que les patients exposés à des messages au point de soins recevaient des vaccinations à un taux plus de deux fois supérieur à celui des groupes de contrôle. Les principales conclusions incluent :
- 49 % des patients ont déclaré que l'information était nouvelle pour eux
- 65 % étaient susceptibles de discuter des vaccins avec leur médecin
- Dans certains cas, la messagerie a entraîné des taux d'administration des vaccins plus de 10 fois supérieurs à ceux du groupe de contrôle
La recherche démontre l'efficacité de fournir des informations sur les vaccins qui soient opportunes et crédibles pour soutenir la confiance et l'adoption des vaccins, même parmi les populations historiquement marginalisées et durant les périodes d'hésitation accrue concernant les vaccins.
Neue Forschungen von Phreesia zeigen, dass die Übermittlung digitaler Impfhinweise an Patienten vor medizinischen Terminen die Impfquote erheblich steigert. Die Studie, die über 20,2 Millionen digitale Impfmitteilungen in allen 50 Bundesstaaten zwischen März 2020 und Mai 2024 analysierte, ergab, dass Patienten, die den point-of-care Nachrichten ausgesetzt waren, Impfungen in einem mehr als doppelt so hohen Maß erhielten wie die Kontrollgruppen. Zu den wichtigsten Erkenntnissen gehören:
- 49% der Patienten gaben an, dass die Informationen neu für sie waren
- 65% waren eher bereit, mit ihrem Arzt über Impfstoffe zu sprechen
- In einigen Fällen führte die Botschaft zu Impfquoten, die mehr als 10-mal höher waren als bei der Kontrollgruppe
Die Forschung zeigt die Wirksamkeit des Bereitstellens zeitnaher, glaubwürdiger Impfinformationen zur Unterstützung des Impfvertrauens und der Akzeptanz, selbst unter historisch benachteiligten Bevölkerungsgruppen und während Phasen erhöhter Impfstoffskepsis.
- Research shows point-of-care messaging more than doubles vaccine uptake rates
- Study analyzed over 20.2 million digital vaccine messages across all 50 states
- 65% of patients exposed to messages were likely to discuss vaccines with their doctor
- In some cases, messaging drove vaccine administration rates more than 10X higher than control groups
- Effective strategy for supporting vaccine confidence among historically marginalized populations
- None.
Insights
This study by Phreesia demonstrates the significant impact of point-of-care digital messaging on vaccine uptake. The research, involving over 20.2 million digital vaccine messages, shows that providing vaccine information just before appointments more than doubles the rate of vaccine uptake. Key findings include:
49% of patients reported receiving new information from these messages65% indicated they were likely to discuss vaccines with their doctor- In some cases, messaging drove vaccine administration rates more than 10 times higher than control groups
These results are particularly noteworthy given the context of increased vaccine hesitancy and declining childhood vaccination rates. The study's large scale and nationwide scope lend credibility to its findings, suggesting that targeted, timely information can significantly influence health decisions. This approach could be a valuable tool in addressing vaccine hesitancy and improving public health outcomes.
Phreesia's research offers a promising strategy to combat vaccine hesitancy and boost immunization rates. The study's timing is crucial, given the backdrop of declining vaccination rates and widespread misinformation. Key implications include:
- Potential to revitalize routine childhood vaccination programs
- Effective method to reach historically marginalized populations
- Opportunity to rebuild public trust in vaccines
The research suggests that digital interventions at the point of care can be a powerful tool in public health campaigns. By providing relevant, credible information just before medical appointments, healthcare providers can capitalize on a critical moment in patient decision-making. This approach could be adapted to address other public health challenges beyond vaccinations, potentially revolutionizing health communication strategies.
Phreesia's study showcases the potential of digital health technologies in improving patient outcomes. The company's platform demonstrates how targeted, timely digital interventions can significantly influence health behaviors. Key technological implications include:
- Scalability of digital health interventions across diverse populations
- Integration of data analytics to personalize health messaging
- Potential for AI-driven optimization of message timing and content
This research validates the effectiveness of digital patient engagement platforms in healthcare delivery. It suggests that companies like Phreesia, which can leverage data and technology to deliver personalized health information at critical moments, may be well-positioned in the evolving healthcare landscape. The study's success could drive increased adoption of similar technologies across the healthcare sector, potentially leading to new market opportunities and partnerships.
Findings reveal that delivering digital, vaccine-related messages before medical appointments more than doubles the rate of vaccine uptake.
ALL-REMOTE COMPANY/
Between March 2020 and May 2024, Phreesia delivered vaccine messages to patients in all 50 states, just before appointments in various care settings. Patients were segmented into subpopulations based on demographics, vaccination status and other factors, and patients received content focused on reducing hesitance, receiving boosters or starting or completing a vaccine series. The data, presented at the Centers for Disease Control and Prevention’s National Immunization Conference, finds:
- Patients exposed to point-of-care messages received incremental vaccinations at a rate more than twice as high, on average, than control groups who did not see point-of-care information;
-
49% of patients who saw point-of-care messages said the information was new to them; and -
65% said they were likely to discuss vaccines with their doctor.
Phreesia’s research shows that exposure to point-of-care vaccine messages shifted patient knowledge, attitudes and behaviors. In some instances, exposure to messaging drove vaccine administration rates more than 10X higher than the control group.
“At Phreesia, we’ve seen firsthand the power of equipping patients and caregivers with relevant, credible vaccine information at key moments in their care journey,” said Phreesia’s SVP of Life Sciences, David Linetsky. “We’re proud to be able to use our digital engagement platform to help patients, including those in historically marginalized groups, make more informed vaccination decisions that can protect both themselves and others against disease.”
“This research shows that accurate, tailored and easy-to-understand reminders go a long way in supporting immunization,” said Christina Suh, MD, MPH, a pediatrician and Director of Clinical Content at Phreesia. "Reinforcing the safety and efficacy of vaccines right before a patient talks to their doctor helps get shots in arms, protecting against vaccine-preventable diseases and saving lives.”
Importantly, these results were seen during a period of unprecedented and mounting vaccine hesitancy across the country. Misinformation about the COVID-19 vaccine proliferated, hampering immunization efforts and negatively impacting vaccine sentiment. Routine childhood vaccination rates also declined during the pandemic and have yet to rebound, with coverage levels no longer reaching the threshold needed for herd immunity from various diseases in many states.
“Phreesia research has shown time and again that the point of care is an important place to engage patients while they’re making decisions about their health,” said Jai Seth, Phreesia’s Associate Director of Strategic Research. “We look forward to continuing to study the impact that outreach in this setting can have on vaccine attitudes and behaviors and exploring new ways our platform can be used to support vaccination in this critical moment.”
About Phreesia
Phreesia is the trusted leader in patient activation, giving providers, life sciences companies, payers and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled approximately 150 million patient visits in 2023—more than 1 in 10 visits across the U.S.—scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240919143574/en/
Media:
Carly Helfand
chelfand@phreesia.com
332-910-6768
Source: Phreesia, Inc.
FAQ
What impact did Phreesia's point-of-care vaccine messages have on vaccination rates?
How many digital vaccine messages did Phreesia's research analyze?
What percentage of patients found the vaccine information from Phreesia's messages to be new?
How likely were patients to discuss vaccines with their doctor after seeing Phreesia's messages?
